KeyBank National Association’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$265K Sell
2,848
-219
-7% -$20.6K ﹤0.01% 1189
2026
Q1
$273K Sell
3,067
-1,265
-29% -$130K ﹤0.01% 1073
2025
Q4
$412K Sell
4,332
-101
-2% -$10.2K ﹤0.01% 902
2025
Q3
$437K Hold
4,433
– – ﹤0.01% 848
2025
Q2
$472K Hold
4,433
– – ﹤0.01% 796
2025
Q1
$404K Hold
4,433
– – ﹤0.01% 847
2024
Q4
$505K Hold
4,433
– – ﹤0.01% 777
2024
Q3
$527K Sell
4,433
-7,609
-63% -$700K ﹤0.01% 754
2024
Q2
$968K Buy
12,042
+1,690
+16% +$154K ﹤0.01% 547
2024
Q1
$955K Sell
10,352
-219
-2% -$21K ﹤0.01% 548
2023
Q4
$1.12M Buy
+10,571
New +$1.07M 0.01% 490

Other funds holding BNTX

KeyBank National Association's BNTX Position: Q2 2026 in Review

KeyBank National Association reduced its BioNTech (BNTX) stake by 7.1% in Q2 2026, selling an estimated $20.6K and leaving 2,848 shares worth $265K. The position accounts for ﹤0.01% of the portfolio, ranked #1189.

KeyBank National Association first reported a position in BNTX in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.12M in Q4 2023. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • KeyBank National Association held 2,848 shares of BioNTech worth $265K as of Q2 2026.
  • KeyBank National Association sold 219 BioNTech shares in Q2 2026, an estimated $20.6K.
  • BioNTech made up ﹤0.01% of KeyBank National Association's portfolio in Q2 2026, its #1189 holding.
  • KeyBank National Association first reported a position in BioNTech in Q4 2023 and has held it in 11 quarters since.
  • KeyBank National Association's BioNTech position peaked at $1.12M in Q4 2023.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on KeyBank National Association's 13F filing for Q2 2026, filed 28 Jul 2026.